A0A2K6M3I5 (A0A2K6M3I5_RHIBE) Rhinopithecus bieti (Black snub-nosed monkey) (Pygathrix bieti)
Eukaryotic translation initiation factor 4E UniProtKBInterProInteractive Modelling
217 aa; Sequence (Fasta) ;
10 identical sequences: Homo sapiens: P06730; Pongo abelii: A0A2J8TQQ5; Pan troglodytes: G2HH86, A0A6D2XVG9; Macaca nemestrina: A0A2K6AUV9; Macaca mulatta: H9ENS9; Macaca fascicularis: I7GAS4; Rhinopithecus roxellana: A0A2K6PUJ2; Chlorocebus sabaeus: A0A0D9QVU1; Colobus angolensis palliatus: A0A2K5JHE0
It is possible new templates exist for this target since these models were created.
Available Structures
38 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Co-crystal structure of eIF4E with nucleotide mimetic inhibitor. |
Heteromer P06730; Q04637; | 1×5O8; 1×SO4; | ||||
Assess | ||||||
Crystal structure of the ternary complex of eIF4E-m7GpppA-4EBP1 peptide |
Heteromer P06730; Q13541; | 1×GTA; | ||||
Assess | ||||||
Improved eIF4E binding peptides by phage display guided design. |
Heteromer P06730; Q04637; | 1×MGO; | ||||
Assess | ||||||
Crystal structure of the ternary complex of eIF4E-M7GTP-4EBP2 peptide |
Heteromer P06730; Q13542; | 1×MGP; | ||||
Assess | ||||||
Co-crystal structure of eIF4E with nucleotide mimetic inhibitor. |
Heteromer P06730; Q04637; | 1×5NX; | ||||
Assess | ||||||
Co-crystal structure of eIF4E with nucleotide mimetic inhibitor. |
Heteromer P06730; Q04637; | 1×5O8; 1×SO4; | ||||
Assess | ||||||
Autonomous VH domain that interacts with eIF4E at the Capped mRNA Binding site. |
Heteromer P06730; | |||||
Assess | ||||||
Crystal Structure of eIF4E Bound to Glycerol and eIF4G1 peptide |
Heteromer P06730; Q04637; | 1×MGO; 1×PGE; 4×SO4; 2×GOL; | ||||
Assess | ||||||
Crystal structure of the human eIF4E-4EBP1 peptide complex without cap |
Heteromer P06730; Q13541; | 1×SO4; 9×UNX; | ||||
Assess | ||||||
Stapled-peptides tailored against initiation of translation |
Heteromer P06730; Q04637; | 1×MGT; | ||||
Assess | ||||||
Co-crystal structure of eIF4E with nucleotide mimetic inhibitor. |
Heteromer P06730; Q13541; | 1×5PQ; | ||||
Assess | ||||||
eIF4E in Complex with a Disulphide-Free Autonomous VH Domain |
Heteromer P06730; | 1×MGO; 1×MES; | ||||
Assess | ||||||
Crystallographic and mass spectrometric characterisation of eIF4E with N7-cap derivatives |
Heteromer P06730; Q13541; | 1×MGV; | ||||
Assess | ||||||
Crystallographic and mass spectrometric characterisation of eIF4E with N7-cap derivatives |
Heteromer P06730; Q13541; | 1×MGO; | ||||
Assess | ||||||
Crystallographic and mass spectrometric characterisation of eIF4E with N7-cap derivatives |
Heteromer P06730; Q13541; | 1×MGQ; | ||||
Assess | ||||||
Engineering Disulphide-Free Autonomous Antibody VH Domains to modulate intracellular pathways |
Heteromer P06730; | |||||
Assess | ||||||
Complex of human eIF4E with the 4E binding protein 4E-BP1 |
Heteromer P06730; Q13541; | |||||
Assess | ||||||
Crystal structure of the human eIF4E-eIF4G complex |
Heteromer P06730; Q04637; | 1×MGP; 2×GOL; | ||||
Assess | ||||||
eIF4E in Complex with a Disulphide-Free Autonomous VH Domain |
Heteromer P06730; | 1×MGO; | ||||
Assess | ||||||
Cap-free structure of eIF4E suggests basis for its allosteric regulation | monomer | |||||
Assess | ||||||
Stapled-peptides tailored against initiation of translation | monomer | 1×NO3; 3×EDO; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF EUKARYOTIC INITIATION FACTOR 4E COMPLEXED WITH 7-METHYL GTP | monomer | 1×MGP; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF EUKARYOTIC INITIATION FACTOR 4E COMPLEXED WITH 7-METHYL GPPPA | monomer | 1×GTA; | ||||
Assess | ||||||
Co-crystal structure of eIF4E with inhibitor | monomer | 1×6LI; 1×GOL; 4×EDO; | ||||
Assess | ||||||
Co-crystal structure of eIF4E with inhibitor | monomer | 1×HLI; 2×EDO; | ||||
Assess | ||||||
Stapled-peptides tailored against initiation of translation | monomer | 1×MGT; 4×IOD; 1×GOL; 1×CL; | ||||
Assess | ||||||
Stapled-peptides tailored against initiation of translation | monomer | 1×MGP; 2×PEG; 1×GOL; | ||||
Assess | ||||||
Crystal Structure of eIF4E in Complex with a Stapled Peptide Derivative | monomer | |||||
Assess | ||||||
Stapled-peptides tailored against initiation of translation | monomer | 1×MGT; | ||||
Assess | ||||||
Water-Bridge Mediates Recognition of mRNA Cap in eIF4E | monomer | 3×GOL; | ||||
Assess | ||||||
The co-complex structure of the translation initiation factor eIF4E with the inhibitor 4EGI-1 revea… | monomer | 1×MGP; 1×33R; | ||||
Assess | ||||||
Stapled-peptides tailored against initiation of translation | monomer | 1×MGP; | ||||
Assess | ||||||
The co-complex structure of the translation initiation factor eIF4E with the inhibitor 4EGI-1 revea… | monomer | 1×MGT; 1×34K; 1×MES; | ||||
Assess | ||||||
Crystal Structure of eIF4e in complex with Compound 7n | monomer | 1×WXL; | ||||
Assess | ||||||
A biphenyl inhibitor of eIF4E targeting an internal binding site enables the design of cell-permeab… | monomer | 1×MGP; 1×Z5D; | ||||
Assess | ||||||
The co-complex structure of the translation initiation factor eIF4E with the inhibitor 4EGI-1 revea… | monomer | 1×M7G; 1×34J; | ||||
Assess | ||||||
Crystal structure of the cap free human translation initiation factor eIF4E | monomer | 6×UNX; | ||||
Assess | ||||||
Cyclic Peptide that Interacts with the eIF4E Capped-mRNA Binding Site | monomer | 1×NA; | ||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
4dt6.1.A | monomer | 0.85 | 1×6LI; | 100.00 | ||
Assess |